Can-Fite BioPharma Ltd. Deferred Tax Assets, Capital Loss Carryforwards
Can-Fite BioPharma Ltd. (CANF) had Deferred Tax Assets, Capital Loss Carryforwards of $157.11 thousand as of 2022-12-31, per its 20-F filed 2023-03-30.
Discontinued › Notes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2023-03-30
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $157.11K.
- 2021-12-31: Deferred Tax Assets, Capital Loss Carryforwards $164.68K.
- 2020-12-31: Deferred Tax Assets, Capital Loss Carryforwards $140.49K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2022-12-31 | $157.11K 20-F · filed 2023-03-30 |
| 2021-12-31 | $164.68K 20-F · filed 2022-03-24 |
| 2020-12-31 | $140.49K 20-F · filed 2021-03-25 |